Publications by authors named "G E Sereda"

Article Synopsis
  • Advances in colorectal cancer (CRC) treatment face challenges due to fast tumor spread and screening issues, especially for early-onset CRC, highlighting the need for better therapies.
  • The Rictor-mTORC2-AKT pathway is critical in promoting metastasis, and selective inhibitors targeting mTORC2, like Veratridine (VTD), show promise in reducing tumor growth and metastasis.
  • VTD acts by destabilizing Rictor, leading to decreased cancer stem cell populations and aggressive tumor behaviors in CRC, offering a new potential approach to treatment.
View Article and Find Full Text PDF

This study is focused on the selective delivery and release of the plant-based anticancer compound eugenol (EUG) in colorectal cancer cells (CRC). EUG is an apoptotic and anti-growth compound in diverse malignant tumors, including CRC. However, EUG's rapid metabolization, excretion, and side effects on normal cells at higher dosages are major limitations of its therapeutic potential.

View Article and Find Full Text PDF

The modern dentifrice industry needs non-toxic materials able to adhere to dentin, occlude dentinal tubules, hold pharmacons at the surface of dentin, and release them on demand to the location the tooth needs them most. Novel dental materials loaded with eugenol or fluoride-ions examined for the release of the pharmacon in an aqueous suspension efficiently adhere to the surface of human dentin and occlude dentinal tubules as evidenced by Scanning Electron Microscopy (SEM). Ultraviolet-visible (UV-vis) absorption spectroscopy and a fluoride-selective electrode quantified the release of pharmacons.

View Article and Find Full Text PDF

Two genes, and , encoding Zinc-finger proteins, were identified earlier as active in barley plants. Based on bioinformatics and sequencing analysis, six SNPs were found in the promoter regions of and one in , among parents of two barley segregating populations, Granal × Baisheshek and Natali × Auksiniai-2. ASQ and Amplifluor markers were developed for and , one SNP in each gene, and in each of two populations, showing simple Mendelian segregation.

View Article and Find Full Text PDF

Conventional biomaterials developed for bone regeneration fail to fully recapitulate the nanoscale structural organization and complex composition of the native bone microenvironment. Therefore, despite promoting osteogenic differentiation of stem cells, they fall short of providing the structural, biochemical, and mechanical stimuli necessary to drive osteogenesis for bone regeneration and function. To address this, we have recently developed a novel strategy to engineer bone-like tissue using a biomimetic approach to achieve rapid and controlled nanoscale mineralization of a cell-laden matrix in the presence of osteopontin, a non-collagenous protein, and a supersaturated solution of calcium and phosphate medium.

View Article and Find Full Text PDF